NM_005199.5:c.56-16C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_005199.5(CHRNG):c.56-16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000742 in 1,614,116 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0038 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00042 ( 5 hom. )
Consequence
CHRNG
NM_005199.5 intron
NM_005199.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.27
Publications
0 publications found
Genes affected
CHRNG (HGNC:1967): (cholinergic receptor nicotinic gamma subunit) The mammalian muscle-type acetylcholine receptor is a transmembrane pentameric glycoprotein with two alpha subunits, one beta, one delta, and one epsilon (in adult skeletal muscle) or gamma (in fetal and denervated muscle) subunit. This gene, which encodes the gamma subunit, is expressed prior to the thirty-third week of gestation in humans. The gamma subunit of the acetylcholine receptor plays a role in neuromuscular organogenesis and ligand binding and disruption of gamma subunit expression prevents the correct localization of the receptor in cell membranes. Mutations in this gene cause Escobar syndrome and a lethal form of multiple pterygium syndrome. Muscle-type acetylcholine receptor is the major antigen in the autoimmune disease myasthenia gravis.[provided by RefSeq, Sep 2009]
CHRNG Gene-Disease associations (from GenCC):
- autosomal recessive multiple pterygium syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet
- CHRNG-associated hypo-akinesia disorder of prenatal onsetInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- lethal multiple pterygium syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
- transient neonatal myasthenia gravisInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-232539976-C-T is Benign according to our data. Variant chr2-232539976-C-T is described in ClinVar as [Benign]. Clinvar id is 3016305.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00383 (584/152332) while in subpopulation AFR AF = 0.0129 (535/41580). AF 95% confidence interval is 0.012. There are 2 homozygotes in GnomAd4. There are 284 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNG | NM_005199.5 | c.56-16C>T | intron_variant | Intron 1 of 11 | ENST00000651502.1 | NP_005190.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNG | ENST00000651502.1 | c.56-16C>T | intron_variant | Intron 1 of 11 | NM_005199.5 | ENSP00000498757.1 | ||||
CHRNG | ENST00000389492.3 | c.56-16C>T | intron_variant | Intron 1 of 10 | 1 | ENSP00000374143.3 | ||||
CHRNG | ENST00000485094.1 | n.77-16C>T | intron_variant | Intron 1 of 4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00384 AC: 584AN: 152214Hom.: 2 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
584
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00116 AC: 291AN: 250078 AF XY: 0.00105 show subpopulations
GnomAD2 exomes
AF:
AC:
291
AN:
250078
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000420 AC: 614AN: 1461784Hom.: 5 Cov.: 33 AF XY: 0.000380 AC XY: 276AN XY: 727194 show subpopulations
GnomAD4 exome
AF:
AC:
614
AN:
1461784
Hom.:
Cov.:
33
AF XY:
AC XY:
276
AN XY:
727194
show subpopulations
African (AFR)
AF:
AC:
437
AN:
33478
American (AMR)
AF:
AC:
39
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26134
East Asian (EAS)
AF:
AC:
16
AN:
39700
South Asian (SAS)
AF:
AC:
18
AN:
86256
European-Finnish (FIN)
AF:
AC:
0
AN:
53350
Middle Eastern (MID)
AF:
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
43
AN:
1111992
Other (OTH)
AF:
AC:
57
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
38
76
115
153
191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00383 AC: 584AN: 152332Hom.: 2 Cov.: 33 AF XY: 0.00381 AC XY: 284AN XY: 74480 show subpopulations
GnomAD4 genome
AF:
AC:
584
AN:
152332
Hom.:
Cov.:
33
AF XY:
AC XY:
284
AN XY:
74480
show subpopulations
African (AFR)
AF:
AC:
535
AN:
41580
American (AMR)
AF:
AC:
33
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
8
AN:
5182
South Asian (SAS)
AF:
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3
AN:
68016
Other (OTH)
AF:
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Mar 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.